This annual symposium celebrates the partnership between Children’s National Hospital (CNH) and the National Institute of Allergy and Infectious Diseases (NIAID). Established in 2017, the CNH-NIAID partnership focuses on advancing the health of children with allergic, immunologic, and infectious diseases through collaborative research and education.
This year, the Symposium will be held on Thursday, June 3rd and Friday, June 4th as a virtual event that highlights current research on COVID-19 and multisystem inflammatory syndrome in children (MIS-C), and the intersectionality of COVID-19, allergy, and immunology on the pediatric population. Keynote speaker Virginia Governor and pediatric neurologist, Ralph Northam, will talk on the COVID-19 pandemic and strategies to reintroduce children into schools and sports.
Questions? Contact us at CN-NIAIDPartnership@childrensnational.org
4th Annual children's national HOSPITAL - niaid Virtual symposium
This virtual symposium is free to attend and participants are required to register.
Click or scan the QR code to register for the event.
Thursday, June 3, 2021
12:00 - 1:20 pm... Clinical Manifestations of SARS-CoV-2 in Children
12:00 - 12:20 pm ... Topic: Post-COVID Cardiac Manifestations in Children Anita Krishnan, MD (Children's National Hospital)
12:20 - 12:40 pm ... Topic: Cytokine Profiling and Immunomodulation in the Setting of MIS-C Hemalatha Srinivasalu, MD (Children's National Hospital)
12:40 - 1:00 pm ... Topic: Evaluating Long-term Outcomes of MIS-C Jane Newburger, MD, MPH (Boston Children's Hospital)
1:00 - 1:20 pm ... Q&A
1:20 - 1:30 pm ... Break
1:30 - 2:50 pm ... Comparative Disease Biology (Comparing Children and Adult Manifestations)
1:30 - 1:50 pm ... Topic:MIS-C in Children Dusan Bogunovic, PhD (Icahn School of Medicine at Mount Sinai)
1:50 - 2:10 pm ... Topic:Evaluating the immunobiology in Pediatric COVID, Adult COVID and MIS-C Susan Conway, MD (Children’s National Hospital)
2:10 - 2:30 pm ... John Tsang, PhD (NIAID)
2:30 - 2:50 pm ... Q&A
2:50 - 3:00 pm ... Break
3:00 - 4:20 pm ... COVID-19 Therapies and Vaccines in the Pediatric Setting
3:00 - 3:20 pm ... Topic: Therapeutics Andrew T. Pavia, MD (University of Utah Health)
3:20 - 3:40 pm ... Topic:Vaccines Alicia Widge, MD (NIAID)
3:00 - 3:20 pm ... Topic:Implementation and Public Health Aspects Cara Biddle, MD, MPH (Children’s National Hospital)
3:00 - 3:20 pm ... Q&A
4:20 - 4:30 pm ... Break
4:30 - 5:00 pm ... Topic: The COVID-19 Pandemic: Strategies to Reintroduce Children into Schools and Sports Virginia Governor Ralph Northam (Keynote Speaker)
Friday, June 4, 2021
10:00 - 11:20 am ... Intersectionality of Allergy, Immunology, and COVID-19
10:00 - 10:20 am ... Topic: Respiratory Issues/Chronic Respiratory Disease William Sheehan, MD (Children’s National Hospital)
10:20 - 10:40 am ... Topic: PID Jessica Durkee-Shock, MD (NIAID)
10:40 - 11:00 am ... Topic:Cancer Andrew Kung, MD, PhD (Memorial Sloan Kettering Cancer Center)
11:00 - 11:20 pm ... Q&A
11:20 - 11:30 am ... Break
11:30 am - 12:50 pm ... Modulating Biologic Factors in Immune Regulation
11:30 - 11:50 am ... Topic:Microbiome Yasmine Belkaid, PhD (NIAID)
11:50 - 12:10 pm ... Topic:T-regs/T-cell Erik Wambre, PhD (Benaroya Research Institute)
12:10 - 12:30 pm ... Topic:B-regs Adora Lin, MD, PhD (Children's National Hospital)
12:30 - 12:50 pm ... Topic:Q&A
12:50 - 1:00 pm ... Break
1:00 - 2:20 pm ... Treatments that Invoke Tolerance in Allergy
1:00 - 1:20 pm ... Topic:Biologics Hemant Sharma, MD, MHS (Children's National Hospital)
1:20 - 1:40 pm ... Topic:Tolerance Protocols Carla M. Davis, MD (Texas Children's Hospital)
1:40 - 2:00 pm ... Topic:Genetic Susceptibility/Maternal Fetal Interaction Michiko K. Oyoshi, MD (Harvard Medical School)
2:00 - 2:20 pm ... Q&A
2:20 - 2:30 pm ET... Closing Remarks
All times listed are in the Eastern timezone.
This schedule is subject to change.
about the partnership
In 2017, The National Institute of Allergy and Infectious Diseases (NIAID) and Children’s National Hospital launched a clinical research partnership devoted to protecting and advancing the health of children with allergic, immunologic, auto-inflammatory, and infectious disease through collaborative research and education. This strategic and novel alliance is supported through the Clinical and Translational Science Institute at Children’s National (CTSI-CN). The partnership, co-led by H. Clifford Lane, M.D., Deputy Director for Clinical Research and Special Projects at NIAID, and Mark Batshaw, M.D., Executive Vice President and Chief Academic Officer at Children’s National, holds the mission to generate and apply knowledge to promote the prevention, diagnosis, treatment, and cure of these childhood diseases through its work together.
For each area, designated investigators from each institution are collaborating to design and conduct clinical research studies that will advance prevention strategies, diagnoses, treatments, and cures for the diverse range of pediatric diseases involving the immune system. Many of these studies will include children at high risk for complications related to their underlying disease or to experimental therapeutics and diagnostic tests they receive. Research participants will have the opportunity to be seen at both Children’s National and the NIH Clinical Center in Bethesda, Maryland. Together, the two institutions provide comprehensive, state-of-the-art pediatric clinical support, infrastructure, and research capacity. These resources protect the safety of children, ensure that they receive the highest quality of care, and offer them the opportunity to participate in cutting-edge clinical research. In addition, the partnership established joint training opportunities for physician-scientists interested in caring for these children while developing their research expertise in pediatric immunology, allergic, and infectious diseases.
The collaboration is supported through an NIAID supplement to the Clinical and Translational Science Institute at Children's National, which is funded by a Clinical and Translational Science Award from NIH’s National Center for Advancing Translational Sciences to Children’s National Hospital and The George Washington University.
EXECUTIVE STEERING COMMITTEE:
Children’s National Hospital - Children’s National, based in Washington, D.C., has served the nation’s children since 1870. Children’s National is one of the nation’s Top 5 pediatric hospitals and, for a second straight year, is ranked No. 1 in newborn care, as well as ranked in all specialties evaluated by U.S. News & World Report. It has been designated two times as a Magnet® hospital, a designation given to hospitals that demonstrate the highest standards of nursing and patient care delivery. This pediatric academic health system offers expert care through a convenient, community-based primary care network and specialty outpatient centers in the D.C. Metropolitan area, including the Maryland suburbs and Northern Virginia. Home to the Children’s Research Institute and the Sheikh Zayed Institute for Pediatric Surgical Innovation, Children’s National is the seventh-highest NIH-funded pediatric institution in the nation. Children’s National is recognized for its expertise and innovation in pediatric care and as a strong voice for children through advocacy at the local, regional and national levels.
National Institute of Allergy and Infectious Diseases (NIAID) - NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. Visit NIAID for news releases, fact sheets and other NIAID-related materials.
September 18, 2018: Inaugural CN-NIAID Symposium
November 8, 2019: 2nd CN-NIAID Symposium